Business News›Prime›Prime Decoder›Why access to 120 medicines including for type-2 diabetes and obesity is becoming easier in India
Pharma
Why access to 120 medicines including for type-2 diabetes and obesity is becoming easier in India
Getty Images
Synopsis
A global tender for procurement of 120 drugs could ease access to some patented medicines in India. An explainer.
The government has allowed India’s healthcare institutions to float global tenders for 120 medicines patented or proprietary medicines that is not sold in the country currently. These include Semaglutide, used for the treatment of Type-2 diabetes and obesity. Here's an explainer to understand the process. What's is the standard practice? In any tender below INR200 crore in India, only class 1 and class 2 Make-in-India manufacturers can
- FONT SIZEAbcSmallAbcMediumAbcLarge
ET
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.